Skip to main content
. 2013 Jun 4;17(3):523–530. doi: 10.1093/icvts/ivt243

Table 2:

Baseline endothelial cell activation markers

All patients (N = 39) Vasoplegia (N = 15) No vasoplegia (N = 24) P-value*
von Willebrand Factor (nM) 45.6 (32.1–64.1) 47.5 (36.9–57.3) 43.1 (25.6–66.4) 0.77
von Willebrand Factor propeptide (nM) 10.1 (7.2–24.5) 25.3 (14.9–48.4) 8.4 (6.6–11.1) <0.001
Osteoprotegerin (pg/ml) 36.2 (19.1–53.5) 26.3 (15.5–46.0) 38.9 (24.6–60.1) 0.09
Angiopoeitin-2 (ng/ml) 2.4 (2.1–3.1) 2.5 (2.1–3.5) 2.4 (2.1–2.8) 0.57
Interleukin-8 (pg/ml) 8.4 (3.5–13.9) 8.3 (5.6–17.0) 8.4 (2.9–13.3) 0.45
Soluble P-selectin (ng/ml) 62.7 (49.0–76.4) 76.0 (62.1–81.6) 54.0 (43.8–72.7) 0.006

Medians and IQRs are shown.

*P-values are given for the comparisons of patients with and without vasoplegia after mitral valve surgery.